Vaccination against SARS-CoV-2 provides an effective tool to combat the COVID-19
pandemic. Here, we combined antigen optimization and nanoparticle display to develop …

To combat the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic,
we formulated the S1 subunit of the virus with two adjuvants, amphiphilic adjuvant …

COVID-19 pandemic has resulted in an unprecedented global public health crisis. It is
obvious that SARS-CoV-2 vaccine is needed to control the global COVID-19 public health …

Massive production of efficacious SARS-CoV-2 vaccines is essential for controlling the
ongoing COVID-19 pandemic. We report here the preclinical development of yeast …

Abstract The coronavirus disease 2019 (COVID‐19) pandemic has become a serious
burden on global public health. Although therapeutic drugs against COVID‐19 have been …

SARS-CoV-2 has caused a global pandemic, infecting millions of people. An effective
preventive vaccine against this virus is urgently needed. Here, we designed and developed …

The COVID-19 pandemic has put global public health at high risk, rapidly spreading around
the world. Although several COVID-19 vaccines are available for mass immunization, the …

Abstract As SARS-CoV-2 Omicron and other variants of concern (VOCs) continue spreading
worldwide, development of antibodies and vaccines to confer broad and protective activity is …

Abstract Global coronavirus disease 2019 (COVID‐19) pandemics highlight the need of
developing vaccines with universal and durable protection against emerging SARS‐CoV‐2 …

Cost-effective, efficacious therapeutics are urgently needed to combat the COVID-19
pandemic. In this study, we used camelid immunization and proteomics to identify a large …